• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅咽管瘤:复发及功能预后预测因素的临床病理分析

Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.

作者信息

Weiner H L, Wisoff J H, Rosenberg M E, Kupersmith M J, Cohen H, Zagzag D, Shiminski-Maher T, Flamm E S, Epstein F J, Miller D C

机构信息

Department of Neurosurgery, New York University Medical Center, New York.

出版信息

Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1. doi: 10.1227/00006123-199412000-00001.

DOI:10.1227/00006123-199412000-00001
PMID:7885544
Abstract

Pathological and clinical data from 56 patients operated on for craniopharyngioma since 1981 were analyzed to determine the utility of dividing patients with this tumor into distinct clinical groups based on recognized pathological type and to determine the prognostic import of brain invasion. Of the tumors in the 30 adult patients, 66% were adamantinomatous, 28% were squamous papillary, and the remainder were mixed. However, of the tumors in the 26 children, 96% were adamantinomatous and none were pure squamous papillary (P < 0.01). Forty-six percent of the children compared with 17% of the adults had brain invasion (P < 0.01). Brain invasion was present in 37% of the adamantinomatous but in only 13% of the squamous papillary tumors. Seventy-seven percent of the children underwent gross total resection (GTR) compared with 27% of the adults (P < 0.01). Sixty-three percent of the squamous papillary tumors underwent GTR compared with 54% of the adamantinomatous and mixed tumors. Follow-up ranged from 7 to 187 months (mean, 49 mo). After subtotal resection, with or without radiation therapy, 58% of the tumors recurred compared with 17% recurrence after GTR (P < 0.01), with a mean time to recurrence of 34 months. In both tumor histological types, subtotal resection was associated with a higher rate of tumor recurrence compared with gross total resection. Among the subtotally resected craniopharyngiomas, 2 of the 3 (67%) squamous papillary and 11 of the 21 (52%) adamantinomatous and mixed tumors recurred. In contrast, among the totally resected tumors, none of the 5 squamous papillary and only 5 of the 25 (20%) adamantinomatous and mixed tumors recurred. There were no significant differences in Karnofsky performance status score, mortality rate, or visual and endocrine outcomes when comparing patients based on histological tumor type. When controlling for age and extent of resection, we found that brain invasion had no significant effect on recurrence rate in totally resected tumors. Based on the limited number of patients in this series, we conclude as follows. 1) Contrary to previous reports, squamous papillary craniopharyngiomas, like adamantinomatous tumors, may recur when subtotally resected. 2) For both tumor variants, the most significant factor associated with craniopharyngioma recurrence is the extent of surgical resection rather than histopathological subtype. 3) Contrary to prior hypotheses, brain invasion in totally resected tumors does not predict higher recurrence. 4) GTR is associated with a significantly lower recurrence rate and can be achieved without sacrificing functional outcome.

摘要

对1981年以来接受颅咽管瘤手术的56例患者的病理和临床数据进行分析,以确定根据公认的病理类型将该肿瘤患者分为不同临床组的实用性,并确定脑侵犯的预后意义。在30例成年患者的肿瘤中,66%为造釉细胞瘤型,28%为鳞状乳头型,其余为混合型。然而,在26例儿童患者的肿瘤中,96%为造釉细胞瘤型,无纯鳞状乳头型(P<0.01)。46%的儿童有脑侵犯,而成人仅为17%(P<0.01)。造釉细胞瘤型肿瘤中37%有脑侵犯,而鳞状乳头型肿瘤仅13%有脑侵犯。77%的儿童接受了全切除(GTR),而成人仅为27%(P<0.01)。63%的鳞状乳头型肿瘤接受了GTR,而造釉细胞瘤型和混合型肿瘤为54%。随访时间为7至187个月(平均49个月)。次全切除后,无论有无放疗,58%的肿瘤复发,而GTR后复发率为17%(P<0.01),平均复发时间为34个月。在两种肿瘤组织学类型中,次全切除与全切除相比,肿瘤复发率更高。在次全切除的颅咽管瘤中,3例鳞状乳头型中的2例(67%)以及21例造釉细胞瘤型和混合型中的11例(52%)复发。相反,在全切除的肿瘤中,5例鳞状乳头型无一复发,25例造釉细胞瘤型和混合型中仅5例(20%)复发。根据肿瘤组织学类型比较患者时,卡氏功能状态评分、死亡率或视觉和内分泌结果无显著差异。在控制年龄和切除范围后,我们发现脑侵犯对全切除肿瘤的复发率无显著影响。基于本系列有限的患者数量,我们得出以下结论。1)与先前报道相反,鳞状乳头型颅咽管瘤与造釉细胞瘤型肿瘤一样,次全切除后可能复发。2)对于两种肿瘤变体,与颅咽管瘤复发相关的最显著因素是手术切除范围而非组织病理学亚型。3)与先前假设相反,全切除肿瘤中的脑侵犯并不能预测更高的复发率。4)GTR与显著较低的复发率相关,且可在不牺牲功能结果的情况下实现。

相似文献

1
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.颅咽管瘤:复发及功能预后预测因素的临床病理分析
Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1. doi: 10.1227/00006123-199412000-00001.
2
Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.经鼻内镜颅咽管瘤切除术:垂体柄与肿瘤关系的重要性。
J Neurosurg. 2018 Sep;129(3):611-619. doi: 10.3171/2017.4.JNS162143. Epub 2017 Sep 29.
3
Pathology of craniopharyngiomas: clinical import of pathological findings.颅咽管瘤的病理学:病理结果的临床意义。
Pediatr Neurosurg. 1994;21 Suppl 1:11-7. doi: 10.1159/000120855.
4
Papillary craniopharyngioma: a clinicopathological study of 48 cases.乳头型颅咽管瘤:48例临床病理研究
J Neurosurg. 1995 Aug;83(2):206-14. doi: 10.3171/jns.1995.83.2.0206.
5
Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.经鼻内镜再次手术治疗颅咽管瘤残留或复发。
J Neurosurg. 2017 Feb;126(2):418-430. doi: 10.3171/2016.1.JNS152238. Epub 2016 May 6.
6
MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.颅咽管瘤中MIB-1免疫反应性:临床病理分析
Clin Neuropathol. 2003 Sep-Oct;22(5):229-34.
7
Craniopharyngioma: a clinicopathological study of 141 cases.颅咽管瘤:141例临床病理研究
Endocr Pathol. 2004 Winter;15(4):339-44. doi: 10.1385/ep:15:4:339.
8
Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features.儿童颅咽管瘤的复发:临床及组织学特征分析
Childs Nerv Syst. 2006 Jan;22(1):50-5. doi: 10.1007/s00381-005-1171-z. Epub 2005 May 14.
9
Suprasellar and recurrent pediatric craniopharyngiomas: expanding indications for the extended endoscopic transsphenoidal approach.鞍上及复发性儿童颅咽管瘤:扩大经鼻内镜扩大经蝶入路的适应证
J Neurosurg Pediatr. 2018 Jan;21(1):72-80. doi: 10.3171/2017.7.PEDS17295. Epub 2017 Nov 10.
10
Stereotactic options in the management of craniopharyngioma.颅咽管瘤治疗中的立体定向治疗方案
Pediatr Neurosurg. 1994;21 Suppl 1:90-7. doi: 10.1159/000120868.

引用本文的文献

1
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction.成人乳头型和造釉细胞瘤型颅咽管瘤的肿瘤特征:垂体-下丘脑轴功能障碍的神经放射学评估及预后预测
Neuroradiology. 2025 Apr 28. doi: 10.1007/s00234-025-03615-z.
2
Finger-like protrusions in adamantinomatous craniopharyngiomas: implications for recurrence and prognosis following complete tumor resection and predictive factors.成釉细胞瘤型颅咽管瘤中的指状突起:对肿瘤全切术后复发及预后的影响和预测因素
Neurosurg Rev. 2025 Feb 15;48(1):242. doi: 10.1007/s10143-025-03412-5.
3
Topography and Radiological Variables as Ancillary Parameters for Evaluating Tissue Adherence, Hypothalamic-Pituitary Dysfunction, and Recurrence in Craniopharyngioma: An Integrated Multidisciplinary Overview.
地形学和放射学变量作为评估颅咽管瘤组织粘连、下丘脑-垂体功能障碍及复发的辅助参数:综合多学科概述
Cancers (Basel). 2024 Jul 13;16(14):2532. doi: 10.3390/cancers16142532.
4
Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature.BRAF 突变型侵袭性颅咽管瘤的靶向治疗:病例报告及文献复习。
J Endocrinol Invest. 2024 Nov;47(11):2835-2842. doi: 10.1007/s40618-024-02382-7. Epub 2024 May 2.
5
Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review.成釉细胞瘤型颅咽管瘤的治疗进展:在当前环境下如何平衡肿瘤控制与生活质量:一项叙述性综述
Front Oncol. 2023 Dec 21;13:1326595. doi: 10.3389/fonc.2023.1326595. eCollection 2023.
6
BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.BRAF-MEK 抑制在新诊断的颅咽管瘤中的应用。
N Engl J Med. 2023 Jul 13;389(2):118-126. doi: 10.1056/NEJMoa2213329.
7
Predictive Factors for Pediatric Craniopharyngioma Recurrence: An Extensive Narrative Review.儿童颅咽管瘤复发的预测因素:一项全面的叙述性综述。
Diagnostics (Basel). 2023 Apr 28;13(9):1588. doi: 10.3390/diagnostics13091588.
8
The molecular pathogenesis of craniopharyngiomas.颅咽管瘤的分子发病机制。
Arch Endocrinol Metab. 2023 Mar 10;67(2):266-275. doi: 10.20945/2359-3997000000600. Epub 2023 Feb 7.
9
Case report and literature review: Resection of retroinfundibular craniopharyngioma via endoscopic far-lateral supracerebellar infratentorial approach.病例报告及文献综述:经内镜远外侧小脑上幕下入路切除漏斗后颅咽管瘤
Front Oncol. 2022 Oct 28;12:976737. doi: 10.3389/fonc.2022.976737. eCollection 2022.
10
Craniopharyngioma and Metabolic Syndrome: A 5-Year Follow-Up Single-Center Experience.颅咽管瘤与代谢综合征:一项单中心5年随访经验
Front Neurol. 2022 Mar 9;13:783737. doi: 10.3389/fneur.2022.783737. eCollection 2022.